Company Filing History:

10 out of 53

Chdi Foundation, Inc.

Eolas Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2013-2022

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11434236 - Halo-substituted piperidines as orexin receptor modulators (2022-09-06),

2. 10894789 - Halo-substituted piperidines as orexin receptor modulators (2021-01-19),

3. 10457675 - Histone deacetylase inhibitors and compositions and methods of use thereof (2019-10-29),

4. 10106535 - Histone deacetylase inhibitors and compositions and methods of use thereof (2018-10-23),

5. 10105363 - Histone deacetylase inhibitors and compositions and methods of use thereof (2018-10-23),

6. 10065948 - Histone deacetylase inhibitors and compositions and methods of use thereof (2018-09-04),

7. 10053453 - Compounds and their use as BACE inhibitors (2018-08-21),

8. 9855267 - Histone deacetylase inhibitors and compositions and methods of use thereof (2018-01-02),

9. 9783488 - Histone deacetylase inhibitors and compositions and methods of use thereof (2017-10-10),

10. 9765054 - Histone deacetylase inhibitors and compositions and methods of use thereof (2017-09-19),

11. 9617259 - Histone deacetylase inhibitors and compositions and methods of use thereof (2017-04-11),

12. 9562021 - Histone deacetylase inhibitors and compositions and methods of use thereof (2017-02-07),

13. 9505736 - Histone deacetylase inhibitors and compositions and methods of use thereof (2016-11-29),

14. 8957090 - Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors (2015-02-17),

15. 8785628 - Triazine derivatives as kinase inhibitors (2014-07-22),

Certainly! Here is an article about inventor Roland W Bürli:

Title: Innovator Spotlight: Roland W Bürli

Introduction:

Roland W Bürli is a prolific inventor hailing from Saffron Walden, GB, with a remarkable track record of 18 patents to his name. His contributions have significantly impacted various fields, particularly in pharmaceuticals.

Latest Patents:

One of Bürli's latest patents includes the development of halo-substituted piperidines as orexin receptor modulators. These compounds have shown promise in treating a wide range of conditions, from substance addiction to hypertension, showcasing Bürli's commitment to innovation in healthcare.

Career Highlights:

Throughout his career, Roland W Bürli has been associated with esteemed organizations such as Chdi Foundation, Inc. and UCB Pharma S.A., where he has played a pivotal role in driving research and development initiatives. His dedication to advancing pharmaceutical science is evident in the groundbreaking patents he has secured.

Collaborations:

Bürli is known to have collaborated with industry experts like Alan Findlay Haughan and Celia Dominguez, highlighting his collaborative spirit and ability to work effectively in diverse teams. These partnerships have undoubtedly enriched the innovation landscape in which Bürli operates.

Conclusion:

In conclusion, Roland W Bürli stands out as a visionary inventor whose contributions have reshaped the pharmaceutical landscape. His expertise, coupled with his passion for addressing unmet medical needs, continues to inspire future generations of inventors to push the boundaries of innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.